GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (WBO:BAX) » Definitions » 3-Year FCF Growth Rate

Baxter International (WBO:BAX) 3-Year FCF Growth Rate : -3.10% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Baxter International 3-Year FCF Growth Rate?

Baxter International's Free Cash Flow per Share for the three months ended in Mar. 2024 was €-0.03.

During the past 12 months, Baxter International's average Free Cash Flow per Share Growth Rate was -15.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -3.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -8.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Baxter International was 65.20% per year. The lowest was -49.80% per year. And the median was 7.90% per year.


Competitive Comparison of Baxter International's 3-Year FCF Growth Rate

For the Medical Instruments & Supplies subindustry, Baxter International's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Baxter International's 3-Year FCF Growth Rate falls into.



Baxter International 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Baxter International  (WBO:BAX) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Baxter International 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Baxter International's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International (WBO:BAX) Business Description

Traded in Other Exchanges
Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.